Summit Therapeutics (SMMT) Research & Development (2016 - 2025)
Historic Research & Development for Summit Therapeutics (SMMT) over the last 9 years, with Q3 2025 value amounting to $131.1 million.
- Summit Therapeutics' Research & Development rose 24751.35% to $131.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $441.8 million, marking a year-over-year increase of 25566.18%. This contributed to the annual value of $150.8 million for FY2024, which is 15353.03% up from last year.
- Summit Therapeutics' Research & Development amounted to $131.1 million in Q3 2025, which was up 24751.35% from $208.0 million recorded in Q2 2025.
- Summit Therapeutics' Research & Development's 5-year high stood at $208.0 million during Q2 2025, with a 5-year trough of $5.4 million in Q4 2022.
- Moreover, its 4-year median value for Research & Development was $30.9 million (2024), whereas its average is $54.9 million.
- Per our database at Business Quant, Summit Therapeutics' Research & Development crashed by 1012.38% in 2023 and then skyrocketed by 57543.67% in 2025.
- Summit Therapeutics' Research & Development (Quarter) stood at $5.4 million in 2022, then soared by 360.71% to $24.8 million in 2023, then skyrocketed by 107.07% to $51.4 million in 2024, then surged by 155.14% to $131.1 million in 2025.
- Its Research & Development was $131.1 million in Q3 2025, compared to $208.0 million in Q2 2025 and $51.3 million in Q1 2025.